Transformable Helical Self-Assembly for Cancerous Golgi Apparatus Disruption
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Golgi apparatus is a major subcellular organelle responsible for drug resistance. Golgi apparatus-targeted nanomechanical disruption provides an attractive approach for killing cancer cells by multimodal mechanism and avoiding drug resistance. Inspired by the poisonous twisted fibrils in Alzheimer’s brain tissue and enhanced rigidity of helical structure in nature, we designed transformable peptide C 6 RVRRF 4 KY that can self-assemble into nontoxic nanoparticles in aqueous medium but transformed into left-handed helical fibrils (L-HFs) after targeting and furin cleavage in the Golgi apparatus of cancer cells. The L-HFs can mechanically disrupt the Golgi apparatus membrane, resulting in inhibition of cytokine secretion, collapse of the cellular structure, and eventually death of cancer cells. Repeated stimulation of the cancers by the precursors causes no acquired drug resistance, showing that mechanical disruption of subcellular organelle is an excellent strategy for cancer therapy without drug resistance. This nanomechanical disruption concept should also be applicable to multidrug-resistant bacteria and viruses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes
Reches, M., & Gazit, E. (2003) · Science · doi:10.1126/science.1082387 · Cited by 2,530
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue
Kollmer, M., Close, W., Funk, L., Rasmussen, J., Bsoul, A., Schierhorn, A., Schmidt, M., Sigurdson, C. J., Jucker, M., & Fändrich, M. (2019) · Nature Communications · doi:10.1038/s41467-019-12683-8 · Cited by 595
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514
A biocompatible condensation reaction for controlled assembly of nanostructures in living cells
Liang, G., Ren, H., & Rao, J. (2010) · Nature Chemistry · doi:10.1038/nchem.480 · Cited by 497
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang, P. (2018) · Europe PMC (PubMed Central) · Cited by 483
Molecular machines open cell membranes
García-López, V., Chen, F., Nilewski, L. G., Duret, G., Aliyan, A., Kolomeisky, A. B., Robinson, J. T., Wang, G., Pal, R., & Tour, J. M. (2017) · Nature · doi:10.1038/nature23657 · Cited by 368
Wang, H., Feng, Z., Wang, Y., Zhou, R., Yang, Z., & Xu, B. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09783 · Cited by 315
Self-citation
Research works printed but not linked: 1
- Shen Y., 2018, Am. J. Cancer Res., 8, 916
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
“After cellular internalization, the C6-containing nanoparticles were selectively delivered to the Golgi apparatus, and were cleaved by the Golgi apparatus-resident protease furin to release the hexapeptide F4KY, which can subsequently self-assemble into lefthanded helical fibrils (L-HFs), mechanically disrupt the Golg…”
BackgroundSelf-citationLiu, J., Cabral, H., & Mi, P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115239 · Cited by 229
Self-citationYang, J., Griffin, A., Qiang, Z., & Ren, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01243-0 · Cited by 196
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside
Abdullah, K. M., Sharma, G., Singh, A. P., & Siddiqui, J. A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02368-w · Cited by 135
“Notably, repeated stimulation of tumor cells by these nanoparticles did not exhibit any acquired form of drug resistance [313].”
Self-Amplifying Assembly of Peptides in Macrophages for Enhanced Inflammatory Treatment
Song, Y., Li, M., Song, N., Liu, X., Wu, G., Zhou, H., Long, J., Shi, L., & Yu, Z. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c01323 · Cited by 65
Nanocarriers for cutting-edge cancer immunotherapies
Hu, J. K., Arvejeh, P. M., Bone, S., Hett, E. C., Marincola, F. M., & Roh, K. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06435-0 · Cited by 48
“For targeting the Golgi apparatus, chondroitin sulfate [315, 316] and six-cysteine peptide (C6) [317, 318] have shown promising results.”
Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics
Xu, X., Xu, S., Wan, J., Wang, D., Pang, X., Gao, Y., Ni, N., Chen, D., & Sun, X. J. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.016 · Cited by 44
Li, R. S., Liu, J., Wen, C., Shi, Y., Ling, J., Cao, Q., Wang, L., Shi, H., Huang, C. Z., & Li, N. (2023) · Science Advances · doi:10.1126/sciadv.adg9601 · Cited by 45
“Studies including our previous results have shown that the in situ transformation of peptide analogs from nontoxic nanoparticles to nanofibrils quickly destroy cell membrane of cancer cells and even subcellular organelles ( 18 – 21 ).”
Self-citationPeptide-based strategies for overcoming multidrug-resistance in cancer therapy
Luo, X., Wu, Y., Zhang, X.-K., Tang, M., Ju, F., Qin, Z., Duns, G. J., Zhang, W., Qin, J., & Luan, X. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109724 · Cited by 33
Jia, S., Ji, S., Zhao, J., Lv, Y., Wang, J., Sun, D., & Ding, D. (2023) · Small Methods · doi:10.1002/smtd.202201409 · Cited by 34
Self-citationZhang, Y., Liu, L., Li, C. M., Huang, C. Z., & Huang, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00865 · Cited by 29
Self-citationDesigning the Next Generation of Biomaterials through Nanoengineering
Davis, R., Duggal, I., Peppas, N. A., & Gaharwar, A. K. (2025) · Advanced Materials · doi:10.1002/adma.202501761 · Cited by 31
Synthetic Nanoassemblies for Regulating Organelles: From Molecular Design to Precision Therapeutics
Guo, Y., Li, P., Guo, X., Yao, C., & Yang, D. (2024) · ACS Nano · doi:10.1021/acsnano.4c10194 · Cited by 25
The Golgi Apparatus as an Anticancer Therapeutic Target
Martins, M., Vieira, J., Pereira‐Leite, C., Saraiva, N., & Fernandes, A. S. (2023) · Biology · doi:10.3390/biology13010001 · Cited by 22
“These structures decreased the viability of MCF-7 and A549 cancer cell lines and reduced the tumor size in MCF-7-tumor-bearing mice [72].”
BackgroundFunctional molecules and nano-materials for the Golgi apparatus-targeted imaging and therapy
Li, R. S., Wen, C., Huang, C. Z., & Li, N. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116714 · Cited by 20
Self-citationEffects of nanoparticle deformability on multiscale biotransport
Gadalla, H. H., Yuan, Z., Chen, Z., Alsuwayyid, F., Das, S., Mitra, H., Ardekani, A. M., Wagner, R., & Yeo, Y. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115445 · Cited by 19
Cho, H., Huh, K. M., Shim, M. S., Cho, Y., Lee, J. Y., Lee, H. S., Kwon, Y. J., & Kang, H. C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115386 · Cited by 20
Bioactive Peptide Nano-assemblies with pH-Triggered Shape Transformation for Antibacterial Therapy
Pal, V. K., & Roy, S. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c03250 · Cited by 18
Nanofibers in Organelles: From Structure Design to Biomedical Applications
Hu, J., Lin, N., Zhang, Y., Xia, F., & Lou, X. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202313139 · Cited by 18
Organic chiral nano- and microfilaments: types, formation, and template applications
Gowda, A., Pathak, S. K., Rohaley, G. A. R., Acharjee, G., Oprandi, A., Williams, R., Prévôt, M. E., & Hegmann, T. (2023) · Materials Horizons · doi:10.1039/d3mh01390a · Cited by 17
Kundu, S., Das, S., Jaiswal, S., & Patra, A. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00415 · Cited by 17
Liu, M., Chen, J., Li, H., Ma, Y., Xiao, Q., Ding, J., Li, J., & Chen, X. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01504a · Cited by 20
Self-citationSaidjalolov, S., Chen, X., Moreno, J., Cognet, M., Wong-Dilworth, L., Bottanelli, F., Sakai, N., & Matile, S. (2024) · JACS Au · doi:10.1021/jacsau.4c00487 · Cited by 15
Wang, S., Xu, X., & Chen, W. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s516260 · Cited by 16
GOLGI: Cancer cell fate control
Martins, M., Fernandes, A. S., & Saraiva, N. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106174 · Cited by 15
Li, X., Huang, Z., Liao, Z., Liu, A., & Huo, S. (2023) · Nanoscale · doi:10.1039/d2nr06621a · Cited by 13
Enzyme‐Activatable Polypeptide for Plasma Membrane Disruption and Antitumor Immunity Elicitation
Liu, J., Li, R. S., Zhang, L., Wang, J., Dong, Q., Xu, Z., Kang, Y., & Xue, P. (2023) · Small · doi:10.1002/smll.202206912 · Cited by 13
Self-citationIn situ supramolecular self-assembly for alleviating multidrug resistance in cancer
Zhao, J., Wu, X., Chen, J., Wu, C., Zhang, R., Yao, Q., Xie, J., & Gao, Y. (2023) · Supramolecular Materials · doi:10.1016/j.supmat.2023.100033 · Cited by 11
Blal, N., Bardi, G., Pompa, P. P., & Guarnieri, D. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202408436 · Cited by 12
Chai, X., Lei, C., Liu, H., Yang, F., Yin, D., Bao, Z., Liu, J., Zhang, Q., Shao, J.-W., Li, R. S., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02825 · Cited by 9
Self-citationOrganelle-oriented nanomedicines in tumor therapy: Targeting, escaping, or collaborating?
Tan, K., Zhang, H., Yang, J., Wang, H., Li, Y., Ding, G., Gu, P., Yang, S., Li, J., & Fan, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.02.040 · Cited by 18
“10b – d) [237].”
Self-citationCui, C., Sun, C., Yuan, P., Tian, S., Xie, H., Xu, F., & Li, H. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2527867 · Cited by 9
“…mechanical disruption of the Golgi apparatus as a promising strategy for cancer therapy that may circumvent conventional resistance mechanism [104]. tan et al. changed the oxygen atom of the phosphate bond in the phosphopeptide (pO1) with a sulphur atom to generate a phosphothiopeptide (pS1).”
Self-citationYin, D., Xiao, L., Wang, X., Liu, J., She, W.-Z., Liu, J., Ling, J., Li, R. S., & Cao, Q. (2023) · Chemosensors · doi:10.3390/chemosensors11090484 · Cited by 7
Self-citationBiomimetic peptide self-assembly: interfacing with biomacromolecules to regulate cellular signaling
Kim, D., Park, G., Seu, M., Hwang, I., Perumandla, S. K., Lee, J., & Ryu, J.-H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01691-6 · Cited by 7
“Forexample, the CCCCCCRVRRFFFFKY initially forms non-toxic nanoparticles in aqueous solution 69 .”
Zhang, H., Geng, R., Zheng, B., Zhang, Z., Zhao, Z., Hu, Y., & Ma, X. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172476 · Cited by 5
An AIEgen-based “turn-on” probe for sensing cancer cells and tiny tumors with high furin expression
Ji, S., Li, S., Gao, H., Wang, J., Wang, K., Nan, W., Chen, H., & Hao, Y. (2023) · Biomaterials Science · doi:10.1039/d2bm01979e · Cited by 5
Self-citationOrganelle-Specific Smart Supramolecular Materials for Bioimaging and Theranostics Application
Bharathidasan, D., & Maity, C. (2024) · Topics in Current Chemistry · doi:10.1007/s41061-024-00483-8 · Cited by 5
Liu, H., Liu, Z., Zhang, H., Huang, K., Liu, X., Jiang, H., & Wang, X. (2024) · Materials Horizons · doi:10.1039/d4mh00613e · Cited by 4
Nanofibers in Organelles: From Structure Design to Biomedical Applications
Hu, J., Lin, N., Zhang, Y., Xia, F., & Lou, X. (2023) · Angewandte Chemie · doi:10.1002/ange.202313139 · Cited by 6
Targeted drug delivery system for Golgi apparatus's diseases
Xu, Y., Jin, Y., Huang, Y., Wen, Y., Gu, Z., & Zhu, Y. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.06.001 · Cited by 6
Kwek, G., Lingesh, S., Chowdhury, S. Z., & Xing, B. (2021) · Chemical Communications · doi:10.1039/d1cc06049j · Cited by 3
Chen, J., & Wang, F. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102714 · Cited by 2
“Research indicates that Golgi stress responses can trigger autophagy and apoptosis, alter tumor cell sensitivity to chemo-therapeutic drugs, and drive the emergence of drug-resistant phenotypes [10,11].”
Surface engineering of theranostic nanomaterials for intracellular trafficking and localization
Sahli, C., Pham, T. T., Madriaga, S. S., Buttny, S., Luadtke, A., & Kenry, K. (2025) · MRS Communications · doi:10.1557/s43579-025-00784-z · Cited by 2
Beyond the cell membrane: subcellular organelle-targeted nanomedicines
Chen, H., Zang, S., Chen, Y., Gui, R., Crețoiu, D., Chen, X., & Xiao, J. N. (2026) · Chemical Communications · doi:10.1039/d5cc07262j · Cited by 2
Strategies for Enhancing Selectivity in Anticancer Metal Complexes
Butcher, P. R., & Sykes, D. (2026) · ACS Omega · doi:10.1021/acsomega.5c11333 · Cited by 2
Small-molecule probes for imaging and impairing the Golgi apparatus in cancer
Kumar, P., Sengupta, P., & Basu, S. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00320b · Cited by 2
Wu, C., Sun, L., Zhu, W., Huang, C., Zhu, Z., & Liu, Z. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00332-8 · Cited by 2
“As a result, Golgi-targeted nanodrug delivery systems have shown promising outcomes in treating tumors, offering bene fi ts such as precise targeting, lower drug doses, and decreased chemotherapy side effects [8, 9].”
Self-citationNanoparticle organelle targeting kinetics: a discussion on application
Pouyanfar, N., Aftabi, P., Farnam, G., Masoumi, N., Shirazi, F. H., & Ghorbani‐Bidkorbeh, F. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107028 · Cited by 3
Peptide-Based Therapeutic Platforms for Addressing Drug Resistance in Breast Cancer
Meur, S., & Karati, D. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10770-7 · Cited by 1
“The expression of survivin is enhanced by ROCK (Rho-associated protein kinase) pathways being activated (Li et al. 2021).”
InfluentialPhotocatalytic Golgi Proteomics Reveals Palmitoylation-Regulated Golgiphagy
Di, Y., Guo, F., Liu, Z., Guo, H., Kong, L., Chen, P. R., & Fan, X. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c13532 · Cited by 3
Liu, M., Peng, Q., Zhai, H., Wu, Y., Ma, Z., Tang, Z., Ouyang, H., Chang, A., Cao, X., Xu, Y., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s607870 · Cited by 1
“183 Furthermore, caveolin-mediated endocytosis is linked to cargo transport within the GA.”
In Situ Peptide Assembly for Cancer Therapy
Liang, G., Sun, X., Ma, Y., Xia, T., Cheng, X., & Liang, G. (2026) · Angewandte Chemie · doi:10.1002/ange.2719299 · Cited by 1
Nanomaterials for Targeting the Golgi Apparatus in Cancer
Aditi, Kochar, A., & Basu, S. (2026) · ACS Applied Engineering Materials · doi:10.1021/acsaenm.6c00806 · Cited by 1
Regulation of cancer cell apoptosis with DNA nanocalculator
Jiang, Y. J., Cheng, F., Zhou, J., Zhan, L., Li, C. M., & Huang, C. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110071
Self-citationIntervention of biophysical effects generated by self-assembly peptides in tumor progression
Bao, X., Peng, J., Ying, X., & Han, M. Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126537 · Cited by 1
Organelle‐Resolved Tetrazine‐ trans ‐Cyclooctene Click Chemistry for Cargo Delivery and Release
Durydivka, O., Chovanec, M., Dzijak, R., Rahm, M., Hrušák, J., Reyes‐Gutierrez, P. E., & Vrábel, M. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71198
“Cysteine-rich and polycysteine motifs have been used as alternative Golgi anchoring elements, as several Golgi-resident proteins depend on cysteine residues or cysteine-rich domains to maintain stable Golgi localization [69, 77].”
Chen, H., Liu, J., Liu, S., Yang, F., Yin, Q., Bao, Z., He, W., Zhang, X., Liu, J., Wang, Z., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.77070
Self-citationOrganelle-Function-Modulated In Situ Assembling Peptide Systems for Intracellular Drug Delivery
Han, Z., Ju, H., Chen, T., Xi, D., & Song, Y. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00723
Organelle-targeted DNA nanomaterials: Design, construction, and application
Li, P., Chen, J., Jia, X., Yao, C., Guo, X., & Yang, D. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100579
Steroid Thioesters to Target Golgi ApparatusPreprint
Zou, L., Tan, W., Zhang, Q., & Xu, B. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15010486/v2
Metadata
- Authors
- Li, R. S., Liu, J., Shi, H., Hu, P. P., Wang, Y., Gao, P. F., Wang, J., Jia, M., Li, H., Li, Y. F., Mao, C., Li, N., & Huang, C. Z.
- Affiliations
- Southwest University (CN)
- Shanxi University (CN)
- Chongqing University (CN)
- Peking University (CN)
- Corresponding author
- Shi, Hu
- Mao, Chengde
- Li, Na
- Huang, Cheng Zhi
- ORCID
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-27
- Volume
- 21
- Issue
- 19
- Pages
- 8455-8465
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W3202035618
- Cited by
- 59
- References
- 62
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 11 · 2023: 13 · 2022: 6 · 2021: 1
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nano Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- China Postdoctoral Science Foundation (2020M670015)
- National Natural Science Foundation of China (21974006, 21976144, 22134005)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Supramolecular Self-Assembly in Materials
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- Golgi apparatus, tumor targeting, peptide self-assembly, furin cleavage, drug resistance, anticancer nanomaterials, multidrug-resistant bacteria, antiviral nanomaterials
- MeSH terms
- Golgi Apparatus, Humans, Neoplasms, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.